Latest news with #Alcon
Associated Press
a day ago
- Business
- Associated Press
betterview Reaches 20,000 Eyes Treated in Four Years
WINTERTHUR, Switzerland--(BUSINESS WIRE)--Jul 29, 2025-- betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of ten clinics and its own surgical center, covering all language regions of Switzerland. This continued expansion has positioned betterview as one of the country's leading providers of laser vision correction. betterview offers a range of refractive surgery procedures, including Femto-LASIK, Trans-PRK, and the modern SMILE Pro method. Treatments are performed using advanced laser systems from manufacturers such as Alcon and Zeiss. In early 2025, the company introduced the SMILE Pro procedure, a minimally invasive laser eye surgery technique. Utilizing the ZEISS VisuMax 800 laser system, the procedure can reduce treatment time to under 10 seconds per eye. The company's growth is driven by a combination of cutting-edge technology, transparent pricing, and patient care. Financing options are available starting at CHF 90 per month. betterview's strategy emphasizes both geographic accessibility and continuous innovation. The 20,000 eyes treated include procedures across all clinic locations and methods, reflecting steady growth since the company's inception. betterview is also the first company in Swiss ophthalmology to establish an independent ombuds office in partnership with the national consumer forum. This offers patients a neutral point of contact for inquiries or complaints and underscores the company's commitment to patient rights and transparency. Since 2021, betterview's ongoing expansion has made it one of the leading laser eye correction providers in Switzerland, with a focus on innovation and nationwide availability. About betterview Founded in 2021 in Winterthur, betterview specializes in refractive eye surgery. The company operates clinics in Zurich, Bern, Basel, Aarau, Lucerne, St. Gallen, Chur, Lugano, and Geneva. Its services include various laser procedures to correct nearsightedness, farsightedness, and astigmatism. betterview uses technology from leading manufacturers such as Alcon and Zeiss, offering treatment methods including Femto-LASIK, Trans-PRK, and SMILE Pro. The company follows a fixed-price model with flexible financing options. All locations are in urban areas and exclusively focus on laser vision correction. Since its founding, betterview has consistently invested in new technologies and expanded its network of locations. The company prioritizes high standards of care and transparent pricing. For more information, View source version on CONTACT: Media Contact: betterview AG Zürcherstrasse 464 8400 Winterthur Switzerland Phone:+41 52 260 20 30 Email:[email protected] Web: KEYWORD: SWITZERLAND EUROPE INDUSTRY KEYWORD: HEALTH OPTICAL SURGERY SOURCE: betterview Copyright Business Wire 2025. PUB: 07/29/2025 03:48 AM/DISC: 07/29/2025 03:48 AM
Yahoo
a day ago
- Business
- Yahoo
betterview Reaches 20,000 Eyes Treated in Four Years
Swiss Laser Eye Surgery Provider Announces Major Business Milestone WINTERTHUR, Switzerland, July 29, 2025--(BUSINESS WIRE)--betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of ten clinics and its own surgical center, covering all language regions of Switzerland. This continued expansion has positioned betterview as one of the country's leading providers of laser vision correction. betterview offers a range of refractive surgery procedures, including Femto-LASIK, Trans-PRK, and the modern SMILE Pro method. Treatments are performed using advanced laser systems from manufacturers such as Alcon and Zeiss. In early 2025, the company introduced the SMILE Pro procedure, a minimally invasive laser eye surgery technique. Utilizing the ZEISS VisuMax 800 laser system, the procedure can reduce treatment time to under 10 seconds per eye. The company's growth is driven by a combination of cutting-edge technology, transparent pricing, and patient care. Financing options are available starting at CHF 90 per month. betterview's strategy emphasizes both geographic accessibility and continuous innovation. The 20,000 eyes treated include procedures across all clinic locations and methods, reflecting steady growth since the company's inception. betterview is also the first company in Swiss ophthalmology to establish an independent ombuds office in partnership with the national consumer forum. This offers patients a neutral point of contact for inquiries or complaints and underscores the company's commitment to patient rights and transparency. Since 2021, betterview's ongoing expansion has made it one of the leading laser eye correction providers in Switzerland, with a focus on innovation and nationwide availability. About betterview Founded in 2021 in Winterthur, betterview specializes in refractive eye surgery. The company operates clinics in Zurich, Bern, Basel, Aarau, Lucerne, St. Gallen, Chur, Lugano, and Geneva. Its services include various laser procedures to correct nearsightedness, farsightedness, and astigmatism. betterview uses technology from leading manufacturers such as Alcon and Zeiss, offering treatment methods including Femto-LASIK, Trans-PRK, and SMILE Pro. The company follows a fixed-price model with flexible financing options. All locations are in urban areas and exclusively focus on laser vision correction. Since its founding, betterview has consistently invested in new technologies and expanded its network of locations. The company prioritizes high standards of care and transparent pricing. For more information, visit View source version on Contacts Media Contact:betterview AGZürcherstrasse 4648400 WinterthurSwitzerlandPhone: +41 52 260 20 30Email: pr@ Web:
Business Wire
a day ago
- Business
- Business Wire
betterview Reaches 20,000 Eyes Treated in Four Years
WINTERTHUR, Switzerland--(BUSINESS WIRE)--betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of ten clinics and its own surgical center, covering all language regions of Switzerland. This continued expansion has positioned betterview as one of the country's leading providers of laser vision correction. betterview offers a range of refractive surgery procedures, including Femto-LASIK, Trans-PRK, and the modern SMILE Pro method. Treatments are performed using advanced laser systems from manufacturers such as Alcon and Zeiss. In early 2025, the company introduced the SMILE Pro procedure, a minimally invasive laser eye surgery technique. Utilizing the ZEISS VisuMax 800 laser system, the procedure can reduce treatment time to under 10 seconds per eye. The company's growth is driven by a combination of cutting-edge technology, transparent pricing, and patient care. Financing options are available starting at CHF 90 per month. betterview's strategy emphasizes both geographic accessibility and continuous innovation. The 20,000 eyes treated include procedures across all clinic locations and methods, reflecting steady growth since the company's inception. betterview is also the first company in Swiss ophthalmology to establish an independent ombuds office in partnership with the national consumer forum. This offers patients a neutral point of contact for inquiries or complaints and underscores the company's commitment to patient rights and transparency. Since 2021, betterview's ongoing expansion has made it one of the leading laser eye correction providers in Switzerland, with a focus on innovation and nationwide availability. About betterview Founded in 2021 in Winterthur, betterview specializes in refractive eye surgery. The company operates clinics in Zurich, Bern, Basel, Aarau, Lucerne, St. Gallen, Chur, Lugano, and Geneva. Its services include various laser procedures to correct nearsightedness, farsightedness, and astigmatism. betterview uses technology from leading manufacturers such as Alcon and Zeiss, offering treatment methods including Femto-LASIK, Trans-PRK, and SMILE Pro. The company follows a fixed-price model with flexible financing options. All locations are in urban areas and exclusively focus on laser vision correction. Since its founding, betterview has consistently invested in new technologies and expanded its network of locations. The company prioritizes high standards of care and transparent pricing.
The Independent
7 days ago
- Automotive
- The Independent
A sensible SUV gets a rally-style makeover in the Vauxhall Mokka GSE
Vauxhall's high-performance, all-electric Mokka GSE has got the green light, and it's set to be the fastest battery-electric Vauxhall ever built. The new GSE has been inspired by the Mokka GSE Rally prototype, using much of the tech and styling tweaks previewed by the concept seen earlier this year. The production Mokka GSE packs an impressive 276bhp, promising thrilling performance that Vauxhall says bridges the gap between rallying excitement and everyday usability. With an instant torque delivery of 345Nm, it rockets from standstill to 62mph in just 5.9 seconds, topping out at a lively 124mph. Under the skin, the Mokka GSE features a raft of performance-enhancing technology alongside a 54kWh battery. It uses the same high-voltage components – motor, inverter, battery, and wiring harness – as the rally-spec Mokka GSE Rally. There's a special Torsen multi-plate limited-slip differential designed to keep power delivery sharp and precise. Meanwhile, an upgraded chassis with new axles, double hydraulic shock absorbers, and a rear axle boasting a 189 per cent increase in roll stiffness over the standard Mokka Electric ensures exceptional handling. Stopping power is provided by huge 380mm front brakes sourced from specialists Alcon, gripped by striking yellow four-piston calipers, while aerodynamically optimised 20-inch alloys are wrapped in Michelin Pilot Sport EV tyres. With a kerb weight comfortably below 1.6 tonnes – remarkably light for a battery-electric vehicle – the Mokka GSE promises not just performance, but also agility and efficiency. There's no word yet on a maximum range for the high-performance Mokka, but the latest models promise 250 miles, so expect the high-performance model to be slightly below that. The Mokka GSE offers three distinct driving modes tailored to the driver's mood and need. 'Sport' mode unlocks its full potential, delivering maximum power and responsiveness. 'Normal' mode provides balanced everyday driving up to 112mph, while 'Eco' trims performance settings to maximise range from the compact 54kWh lithium-ion battery. Visually, the Mokka GSE looks the part. Exclusive design details inspired by its rally sibling ensure it stands out. A purposeful front spoiler, bespoke rear accents, and unique yellow and black GSE badging highlight the car's motorsport DNA. Inside, Vauxhall hasn't held back either. The cabin is crafted around performance-focused details, dominated by sporty Alcantara-clad GSE seats featuring integrated headrests, stylish yellow stitching, and a distinctive white centre stripe. Matching Alcantara inserts on the doors reinforce the sporty theme. Technology hasn't been overlooked, with the driver facing a customisable 10-inch digital information display that includes specialised GSE performance metrics such as acceleration data, G-force monitoring, and battery management insights. The central colour touchscreen echoes these cues, ensuring the driver is fully informed and engaged. Revealing the new Mokka GSE, Vauxhall's managing director Steve Catlin summed it up nicely: "The new Mokka GSE brings motorsport energy to the streets. Using years of pioneering electric motorsport experience, we've poured our best engineering, power, and handling into a car designed for daily thrills." Pricing and first delivery times aren't known yet, but with the level of technology on offer, we'd expect it to be just above the £37,280 of the electric Mokka Ultimate model, probably coming in at just under £40,000 to avoid the luxury car tax. We'd expect this first GSE model to arrive in showrooms towards the end of this year.
Yahoo
23-07-2025
- Business
- Yahoo
Should You Continue to Hold Alcon (ALC)?
Aristotle Capital Management, LLC, an investment management company, released its 'Value Equity Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. Although the U.S. equity market started with volatility in the second quarter, it rebounded with strength, with the S&P 500 Index rising 10.94% during the quarter. The composite returned 4.88% gross of fees (4.75% net of fees) in the first quarter, outperforming the 3.78% return of the Russell 1000 Value Index and underperforming the 10.94% return of the S&P 500 Index. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second quarter 2025 investor letter, Aristotle Capital Value Equity Strategy highlighted stocks such as Alcon Inc. (NYSE:ALC). Headquartered in Geneva, Switzerland, Alcon Inc. (NYSE:ALC) engages in the research, development, manufacturing, and distribution of eye care products. The one-month return of Alcon Inc. (NYSE:ALC) was 1.24%, and its shares lost 4.06% of their value over the last 52 weeks. On July 22, 2025, Alcon Inc. (NYSE:ALC) stock closed at $88.66 per share, with a market capitalization of $43.853 billion. Aristotle Capital Value Equity Strategy stated the following regarding Alcon Inc. (NYSE:ALC) in its second quarter 2025 investor letter: "Alcon Inc. (NYSE:ALC), a global leader in eye care, was one of the largest detractors during the quarter. Aside from its earnings report, there was little material news, and we did not view anything in the report as affecting the company's long-term fundamentals. While quarterly updates can influence sentiment, our focus remains on the strength and quality of the business. Alcon operates in a resilient, oligopolistic industry with high barriers to entry and recurring revenue streams tied to its large installed base of cataract surgery systems. It also continues to innovate across product categories, including its premium intraocular lens portfolio (e.g., PanOptix, Vivity), ultra-premium daily contact lenses (e.g., Dailies Total1) and over-the-counter products, such as Systane for dry eyes. Since its spinoff from Novartis in 2019, the company has also demonstrated greater agility in R&D, commercial execution and capital allocation—catalysts we previously identified. More broadly, we believe Alcon's ability to strengthen its partnerships with eye care professionals and broaden access to underutilized premium technologies makes the company uniquely positioned to benefit from an aging population, increased access to eye care in emerging markets, and rising awareness and diagnosis of chronic dry eye conditions." A doctor wearing scrubs using a centurion vision system to check a patient's eye. Alcon Inc. (NYSE:ALC) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held Alcon Inc. (NYSE:ALC) at the end of the first quarter, which was 40 in the previous quarter. Alcon Inc. (NYSE:ALC) reported sales of $2.5 billion in Q1 2025 and sales growth of 3%. While we acknowledge the potential of Alcon Inc. (NYSE:ALC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Alcon Inc. (NYSE:ALC) and shared the list of best 52-week low stocks to buy. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
